TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Loss of TREM2 function impairs phagocytosis and correlates with decreased soluble TREM2 in biological fluids of patients with neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phagocytic capability of microglia has been shown to be affected by risk factors for AD, such as TREM2 and CD33 (Griciuc et al., 2013; Kleinberger et al., 2014).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Kleinberger et al., 2014
In the citing paper
“TREM2 rare genetic variants associated with AD risk impair microglial lipid sensing and phagocytosis (Kleinberger et al., 2014; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Kleinberger et al., 2014
In the citing paper
“TREM2 has often been referred to as a phagocytic receptor as it was demonstrated to be involved in microglia phagocytosis of apoptotic neurons [46], myelin [8] and β-amyloid [24].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [24]
In the citing paper
“The most common coding variant, R47H, results in a reduction of TREM2 function and was found to increase risk for developing AD three- to five-fold, suggesting that TREM2 is protective in AD.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [33]
In the citing paper
“Several other TREM2 variants associated with AD and frontotemporal dementia (FTD) have also been found to confer partial loss-of-function, as they impair TREM2 binding to ligands, maturation, ectodomain shedding and microglial phagocytic activity [33].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [33]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141 · cited 2×
“(%) 113 (58)/81 (42) 55 (63)/33 (37) 38 (68)/18 (32) 20 (40)/30 (60) 0.”
BackgroundFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citationVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · cited 2×
“(%) 103 (60)/69 (40) 55 (64)/31 (36) 36 (71)/15 (29) 12 (34)/23 (66) 0.”
BackgroundCSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176 · cited 3×
“(%) 103 (60)/69 (40) 55 (64)/31 (36) 36 (71)/15 (29) 12 (34)/23 (66) 0.”
BackgroundMethodTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 2×
“Impaired phagocytosis in TREM2 mutant cells Reduction of cell surface TREM2 in microglia cells, the cell type in which TREM2 is selectively expressed within the brain, was reported to reduce removal of cellular debris and apoptotic neurons (14).”
BackgroundControl of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
Self-citation
Cited by
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
“However, the biology of TREM2, a Type 1 single-transmembrane receptor which is principally but not exclusively expressed in microglia and undergoes ADAM/ c-secretase processing (Wunderlich et al, 2013; Kleinberger et al, 2014), is incompletely understood [reviewed in (Lue et al, 2015)].”
BackgroundSelf-citationAlzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationMicroglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Self-citationImmune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Metadata
- Authors
- Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., Tahirovic, S., Lleó, A., Alcolea, D., Fortea, J., Willem, M., Lammich, S., Molinuevo, J. L., Sánchez-Valle, R., Antonell, A., Ramirez, A., Heneka, M. T., Sleegers, K., van der Zee, J., Martin, J.-J., Engelborghs, S., Demirtas-Tatlidede, A., Zetterberg, H., Van Broeckhoven, C., Gurvit, H., Wyss-Coray, T., Hardy, J., Colonna, M., & Haass, C.
- Affiliations
- Munich Cluster for Systems Neurology (DE)
- Washington University in St. Louis (US)
- Adolf-Butenandt Institute, Biochemistry, Ludwig-Maximilians University Munich, 80336 Munich, Germany.
- VA Palo Alto Health Care System (US)
- German Center for Neurodegenerative Diseases (DE)
- University of Antwerp (BE)
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- German Center for Neurodegenerative Diseases (DZNE), Munich, 80336 Munich, Germany.
- Universitat Autònoma de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Alzheimer’s Disease and Other Cognitive Disorders Unit, Neurology Service, ICN Hospital Clinic i Universitari, 08036 Barcelona, Spain.
- Department of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany.
- University Hospital Bonn (DE)
- Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, 2610 Antwerp, Belgium.
- Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey.
- UCL Queen Square Institute of Neurology (GB)
- Istanbul University (TR)
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Corresponding author
- Haass, Christian
- ORCID
- Kleinberger, Gernot
- Yamanishi, Yoshinori
- Czirr, Eva
- Lohmann, Ebba
- Wenninger-Weinzierl, Andrea
- Mazaheri, Fargol
- Lleó, Alberto
- Alcolea, Daniel
- Fortea, Juan
- Willem, Michael
- Molinuevo, José L.
- Antonell, Anna
- Heneka, Michael T.
- Sleegers, Kristel
- Martin, Jean-Jacques
- Engelborghs, Sebastiaan
- Zetterberg, Henrik
- Gurvit, Hakan
- Hardy, John
- Colonna, Marco
- Haass, Christian
- Venue
- Science Translational Medicine
- Published
- 2014-07-02
- Volume
- 6
- Issue
- 243
- Pages
- 243ra86-243ra86
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W1997816650
- Cited by
- 798
- References
- 49
- Citations by year
- 2026: 47 · 2025: 57 · 2024: 75 · 2023: 69 · 2022: 79 · 2021: 87 · 2020: 87 · 2019: 67 · 2018: 63 · 2017: 51 · 2016: 55 · 2015: 53 · 2014: 6
- FWCI
- 28.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (26893063)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, missense mutations, frontotemporal dementia, Alzheimer's disease, neurodegeneration, phagocytosis, soluble TREM2, ADAM proteases, microglia, cerebrospinal fluid, innate immune receptors, Nasu-Hakola disease
- MeSH terms
- Alzheimer Disease, Biological Transport, Cell Line, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Humans, Membrane Glycoproteins, Mutation, Phagocytosis, Receptors, Immunologic, Neurodegenerative Diseases, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. https://app.cochat.ai/papers/10.1126/scitranslmed.3009093
- The paper
- Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., Tahirovic, S., Lleó, A., Alcolea, D., Fortea, J., Willem, M., Lammich, S., Molinuevo, J. L., Sánchez-Valle, R., Antonell, A., . . . Haass, C. (2014). TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3009093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.